DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.33	3.03	4.54	4.73	4.71	7.41
Short-Term Investments	51.99	41.12	48.35	28.77	40.41	20.1
Cash & Short-Term Investments	55.32	44.15	52.9	33.5	45.11	27.51
Cash Growth	10.20%	-16.54%	57.89%	-25.74%	64.00%	249.16%
Other Receivables	0.26	0.24	0.37	0.08	0.13	0.34
Receivables	0.26	0.24	0.37	0.08	0.13	0.34
Prepaid Expenses	0.45	0.23	0.41	0.21	0.08	0.06
Other Current Assets	0.2	-	-	0.04	0.11	0.01
Total Current Assets	56.22	44.61	53.68	33.84	45.44	27.92
Property, Plant & Equipment	0.37	0.43	0.49	0.56	0.11	0.17
Other Long-Term Assets	-	1.31	-	-	-	-
Total Assets	57.05	46.35	54.16	34.4	45.55	28.1
Accounts Payable	1.92	0.94	0.93	0.73	0.51	1.1
Accrued Expenses	3.24	4.35	1.78	1.37	0.97	0.86
Current Portion of Leases	0.11	0.1	0.08	0.07	0.05	0.07
Total Current Liabilities	5.27	5.39	2.79	2.17	1.52	2.03
Long-Term Leases	0.16	0.24	0.32	0.4	0	0.05
Total Liabilities	5.43	5.63	3.1	2.57	1.53	2.08
Additional Paid-In Capital	215.6	180.7	166.61	128.08	126.58	94.93
Retained Earnings	-164.03	-140	-115.56	-96.18	-82.5	-68.91
Comprehensive Income & Other	0.05	0.02	0.01	-0.07	-0.05	-0
Shareholders' Equity	51.62	40.72	51.06	31.83	44.02	26.01
Total Liabilities & Equity	57.05	46.35	54.16	34.4	45.55	28.1
Total Debt	0.27	0.34	0.4	0.47	0.05	0.12
Net Cash (Debt)	55.05	43.81	52.5	33.03	45.06	27.39
Net Cash Growth	10.47%	-16.55%	58.92%	-26.69%	64.52%	255.70%
Net Cash Per Share	1.23	1.08	1.61	1.25	2.17	1.75
Filing Date Shares Outstanding	52.08	42.86	37.96	26.46	26.44	18.78
Total Common Shares Outstanding	52.08	42.82	37.96	26.44	26.44	18.75
Working Capital	50.96	39.22	50.89	31.67	43.92	25.89
Book Value Per Share	0.99	0.95	1.35	1.20	1.66	1.39
Tangible Book Value	51.62	40.72	51.06	31.83	44.02	26.01
Tangible Book Value Per Share	0.99	0.95	1.35	1.20	1.66	1.39
Machinery	0.27	0.25	0.22	0.2	0.14	0.13
Leasehold Improvements	0.02	0.02	0.02	0.02	0	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q